Maternal Spindle Transfer to Overcome Infertility: Where We Stand
Donate
At the International IVF Initiative, we are committed to providing free access to our educational sessions, webinars, and resources for professionals and individuals passionate about advancing reproductive medicine. We believe that cost should never be a barrier to knowledge and collaboration. By contributing, you’re ensuring that valuable educational resources, expert insights, and collaborative opportunities remain open to all without financial barriers. Together, we can continue to foster a global community dedicated to innovation and excellence in the field of IVF.
Your Donation
Thank you!
Maternal Spindle Transfer to Overcome Infertility: Where We Stand
Dr. Nuno Costa-Borges
animal cloning, having accomplished the first animals successfully cloned in Spain in 2009.
After finishing his PhD at the University Autonomous of Barcelona, he joined the embryology team of IVI Barcelona, where he has worked as a clinical embryologist. Later on, he co-founded Embryotools, where he has been devoted on offering QC tests, training and consulting services to the IVF community worldwide. Additionally, as scientific director of Embryotools, Nuno has also been committed to the development of new IVF techniques, such as, the flicking method for the biopsy of blastocysts or the maternal spindle transfer technique to prevent the transmission of mitochondrial diseases or to treat infertility problems related to poor oocyte quality as alternatives to conventional oocyte donation programs. Nuno’s work has led to several peer-reviewed publications and he has been invited speaker in numerous international conferences and scientific meetings, as well as, awarded with prestigious prizes and grants. Stands out two recent awards, the congress Paper Prize of the American Society of Reproductive Medicine (ASRM) in 2017 and the IVI foundation award
in 2019. He has produced the embryos that resulted in the world’s first baby after maternal spindle transfer for infertility.